Thalamic aphasia and SARS-CoV-2 infection (COVID-19)
1 Department of Neurology. Neuroceuta, Virgen de Africa Clinic. Ceuta, Spain.
2 Department of Eastern Medicine, Government College University. Faisalabad. Pakistan.
Review Article
World Journal of Advanced Research and Reviews, 2024, 21(03), 842–844
Publication history:
Received on 01 February 2024; revised on 06 March 2024; accepted on 09 March 2024
Abstract:
Damage to the thalamus that results in thalamic aphasia, a language disability, is typically associated with vascular events, tumours, or degenerative disorders. There is growing interest in examining the relationship between COVID-19 and thalamic aphasia due to its association with several neurological problems, including strokes and minor lesions that may affect the thalamus. The virus's ability to induce hypercoagulable states and systemic inflammation, which may result in thalamic ischemic strokes and interfere with language processing networks, has sparked this interest. In light of the COVID-19 pandemic's continuous nature, more investigation is necessary to fully comprehend the virus's neurological effects, particularly any potential connections to thalamic aphasia, in order to diagnose and treat thalamic aphasia, forecast language recovery, and customise rehabilitation plans for those affected, including those recuperating from COVID-19-related neurological complications.
Keywords:
Thalamic aphasia; COVID-19; Stroke; SARS-CoV-2
Full text article in PDF:
Copyright information:
Copyright © 2024 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0